Related Experiment Videos
Biostatistical basis of elective node dissection for malignant melanoma
Annals of Surgery
|July 1, 1977
Summary
Elective node dissection for malignant melanoma is valid. Deeper invasion correlates with lymph node metastasis, influencing recurrence rates and cure.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Malignant melanoma management involves decisions regarding lymph node status.
- Elective node dissection (END) was historically performed for primary melanoma.
Purpose of the Study:
- To evaluate the efficacy of patient selection for elective node dissection in primary malignant melanoma.
- To assess the correlation between primary lesion characteristics and lymph node involvement.
Main Methods:
- Retrospective analysis of 259 patients undergoing END (1954-1964).
- Prospective evaluation of 258 patients using Clark's level of invasion (since 1972).
- Comparison of cure rates between END and wide excision alone.
Main Results:
- Microscopic metastases found in 15% of END patients.
- 10-year cure rates varied significantly based on nodal involvement: 67% (microscopic) to 15% (multiple nodes).
- Wide excision alone had an 18% rate of subsequent therapeutic lymphadenectomy and a 6% 10-year cure rate.
- Clark's level of invasion correlated with lymph node metastasis, extent of involvement, and recurrence rates.
Conclusions:
- The concept of elective node dissection for malignant melanoma is supported by the data.
- Primary lesion depth (Clark's level) is a crucial factor in selecting patients for nodal assessment.
- Accurate staging through nodal evaluation impacts treatment strategies and patient outcomes.